" class="no-js "lang="en-US"> Jeff Legos Archives - Pharmtech Focus
Wednesday, February 01, 2023

Breaking News

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12 CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology ClariMed Launches Integrated Medical Device Services Partner

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting | PTF

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Read more

Diseases

 New Phase III Data Show Novartis Tislelizumab Significantly Extended Median Overall Survival by More Than 6 Months in First-line Advanced Esophageal Cancer in Combination With Chemotherapy | Pharmtech Focus

New Phase III Data Show Novartis Tislelizumab Significantly Extended Median Overall Survival by More Than 6 Months in First-line Advanced Esophageal Cancer in Combination With Chemotherapy

Today Novartis announced results from the Phase III RATIONALE 306 trial showing tislelizumab plus chemotherapy […]

Diseases

 Novartis Tislelizumab plus Chemotherapy Significantly Improved Overall Survival as First-line Treatment for Advanced Esophageal Cancer in Phase III Study | Pharmtech Focus

Novartis Tislelizumab plus Chemotherapy Significantly Improved Overall Survival as First-line Treatment for Advanced Esophageal Cancer in Phase III Study

Novartis today announced positive topline results from an interim analysis of the Phase III RATIONALE […]

  1. MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease

    Diseases

     Read more
  2. Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome

    Diseases

     Read more
  3. Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear

    News

     Read more
  4. Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors

    News

     Read more
  5. Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors

    Appointments

     Read more